Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection of Multidrug-Resistant Tuberculosis

Authors: Anita, Sari Septiani Tangke, Rusdina Bte Ladju, Nasrum Massi

Abstract:

New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. The microscopic-observation drug-susceptibility (MODS) assay is a rapid, accurate and simple liquid culture method to detect multidrug-resistant tuberculosis (MDR-TB). MODS were evaluated to determine a lower and same concentration of isoniazid and rifampin for detection of MDR-TB. Direct drug-susceptibility testing was performed with the use of the MODS assay. Drug-sensitive control strains were tested daily. The drug concentrations that used for both isoniazid and rifampin were at the same concentration: 0.16, 0.08 and 0.04μg per milliliter. We tested 56 M. tuberculosis clinical isolates and the control strains M. tuberculosis H37RV. All concentration showed same result. Of 53 M. tuberculosis clinical isolates, 14 were MDR-TB, 38 were susceptible with isoniazid and rifampin, 1 was resistant with isoniazid only. Drug-susceptibility testing was performed with the use of the proportion method using Mycobacteria Growth Indicator Tube (MGIT) system as reference. The result of MODS assay using lower concentration was significance (P<0.001) compare with the reference methods.

A lower and same concentration of isoniazid and rifampin can be used to detect MDR-TB. Operational cost and application can be more efficient and easier in resource-limited environments. However, additional studies evaluating the MODS using lower and same concentration of isoniazid and rifampin must be conducted with a larger number of clinical isolates.

Keywords: Isoniazid, MODS assay, MDR-TB, Rifampin.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1092962

References:

[1] J. Crofton, P. Chaulet, and D. Maher. Guidelines for the Management of Drug-Resistant Tuberculosis. World Health Organization, Geneva, Switzerland. 1997.
[2] C. B. Inderlied, and M. Salfinger. Antimycobacterial Agents and Susceptibility Tests. In Manual of Clinical Microbiology, 7th ed. P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken, Ed. American Society for Microbiology, Washington, D.C. 1999, pp. 1601–1623.
[3] P. T. Kent and G. P. Kubica. Public Health Mycobacteriology—A Guide for the Level III Laboratory. Centers for Disease Control, U.S. Department of Health and Human Services, Atlanta, Georgia. 1985.
[4] S. H. Siddiqi, J. E Hawkins, and A. Laszlo. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J. Clin. Microbiol. 1985, 22:919–923.
[5] Caviedes L, Lee TS, Gilman RH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000; 38:1203–8.
[6] Bwanga F, Hoffner S, Haile M, Joloba M. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis. 2009;9:67.
[7] Moore DA, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004;42(10):4432–4437.
[8] Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355:1539–50.
[9] Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2007; 45(4):1093–1097.
[10] Michael JS, Daley P, Armstrong L, et al. Prospective evaluation of microscopic observation drug-susceptibility (MODS) assay for the diagnosis of active tuberculosis (TB) in India – preliminary analysis. Int J Infect Dis. 2008; 12(Suppl 1):e324.
[11] Mello FCQ, Arias MS, Rosales S, et al. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007;45(10):3387–3389.
[12] Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008; 12(3):332–337.
[13] Arias M, Mello FC, Pavón A, et al. Clinical evaluation of the Microscopic observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis. 2007;44(5):674–680.
[14] Limaye K, Kanade S, Nataraj G, Mehta P. Utility of microscopic observation of drug susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. Indian J Tuberc. 2010; 57(4):207–212.
[15] Boonchai C, Myo Nyein A, Saiyud M, Yuthichai K, et al. Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB. Dove Press Journal: Infection and Drug Resistance. 2012:79-86
[16] Walter P, William B, Richard C, et al. Performance of the Microscopic Observation Drug Susceptibility Assay in Drug Susceptibility Testing for Mycobacterium tuberculosis. Journal of Clinical Microbiology. Vol. 40, No 12. 2002;4750-4752
[17] Laboratory services in TB control.Parts I, II, and III. Geneva: World Health Organization, 1998. (Publication no.WHO/tb/98.258.)
[18] Enrico T, Marta B, Alessandra F, and M. Tullia S. Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of Proportion. Journal of Clinical Microbiology. Vol. 40, No 2. 2002;607-610
[19] Enrico Tortoli, and C. Piersimoni. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Alpe Adria Microbiol. Journal. 1998; 7:275–283